First Horizon Advisors’s Twist Bioscience TWST Stock Holding History

First Horizon Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$24.2K	Sell	658 -159	-19%	-$5.49K	﹤0.01%	1341
2025 Q1	$32.1K	Buy	817 +6	+0.7%	+$270	﹤0.01%	1129
2024 Q4	$37.7K	Buy	811 +109	+16%	+$4.93K	﹤0.01%	1066
2024 Q3	$31.7K	Sell	702 -87	-11%	-$4.14K	﹤0.01%	1188
2024 Q2	$38.9K	Buy	789 +84	+12%	+$3.42K	﹤0.01%	1023
2024 Q1	$24.2K	Buy	705 +62	+10%	+$2.24K	﹤0.01%	1275
2023 Q4	$23.7K	Sell	643 -13	-2%	-$301	﹤0.01%	1270
2023 Q3	$13.3K	Sell	656 -370	-36%	-$8.13K	﹤0.01%	1404
2023 Q2	$21K	Sell	1,026 -109	-10%	-$1.63K	﹤0.01%	1251
2023 Q1	$17.1K	Sell	1,135 -40	-3%	-$884	﹤0.01%	1319
2022 Q4	$28K	Buy	+1,175	New	+$34.1K	﹤0.01%	1129

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

First Horizon Advisors's TWST Position: Q2 2025 in Review

First Horizon Advisors reduced its Twist Bioscience (TWST) stake by 19% in Q2 2025, selling an estimated $5.49K and leaving 658 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1341.

First Horizon Advisors first reported a position in TWST in Q4 2022 and has held it in 11 quarters since. The position peaked at $38.9K in Q2 2024. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

First Horizon Advisors held 658 shares of Twist Bioscience worth $24.2K as of Q2 2025.
First Horizon Advisors sold 159 Twist Bioscience shares in Q2 2025, an estimated $5.49K.
Twist Bioscience made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1341 holding.
First Horizon Advisors first reported a position in Twist Bioscience in Q4 2022 and has held it in 11 quarters since.
First Horizon Advisors's Twist Bioscience position peaked at $38.9K in Q2 2024.
244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.